tiprankstipranks
China SXT Pharmaceuticals Inc (SXTC)
NASDAQ:SXTC
Holding SXTC?
Track your performance easily

China SXT Pharmaceuticals (SXTC) Income Statement

219 Followers

China SXT Pharmaceuticals Income Statement

Last quarter (Q ), China SXT Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q, China SXT Pharmaceuticals's net income was $―. See China SXT Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
-$ 1.93M$ 1.97M$ 2.60M$ 4.78M$ 5.16M
Cost of Revenue
-$ 1.37M$ 1.55M$ 1.35M$ 1.94M$ 2.46M
Gross Profit
-$ 553.97K$ 426.27K$ 1.25M$ 2.84M$ 2.70M
Operating Expense
-$ 2.65M$ 6.03M$ 6.44M$ 6.97M$ 4.04M
Operating Income
-$ -2.09M$ -4.06M$ -5.19M$ -2.20M$ -1.34M
Net Non Operating Interest Income Expense
-$ -544.28K$ -476.78K$ -36.70K$ -1.62M$ -3.35M
Other Income Expense
-$ 39.04K$ 149.51K$ -181.58K$ -871.65K$ 5.70M
Pretax Income
-$ -3.10M$ -5.93M$ -5.41M$ -2.94M$ -10.39M
Tax Provision
---$ 328.15K$ -192.68K$ -101.72K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-$ -3.10M$ -5.93M$ -5.74M$ -2.75M$ -10.29M
Basic EPS
-$ -3.57$ -0.89$ -138.00$ -4.75-
Diluted EPS
-$ -3.57$ -0.89$ -138.00$ -4.75$ -10.50
Basic Average Shares
-$ 867.42K$ 6.67M$ 41.59K$ 575.64K$ 989.15K
Diluted Average Shares
-$ 867.42K$ 6.67M$ 41.56K$ 575.64K$ 989.15K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-$ 4.02M$ 7.58M$ 7.79M$ 6.97M$ 6.50M
Net Income From Continuing And Discontinued Operation
-$ -3.10M$ -5.93M$ -5.74M$ -2.75M$ -10.29M
Normalized Income
-$ -2.64M$ -7.81M---
Interest Expense
------
EBIT
-$ -2.55M$ -5.61M$ -5.19M$ -2.20M$ -7.04M
EBITDA
-$ -2.35M$ -5.36M$ -4.87M$ -1.85M$ -6.71M
Currency in USD

China SXT Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis